Dr. Reddy's Laboratories500124Pharmaceuticals
Analyst recommended buying Dr. Reddy's as stock tests its 200-day moving average with strong volumes
- 200 day moving average
- 12,947 level
- Volume
- 3.24 million shares
- Target price
- 1,300 level
- Stop loss
- 1,220
Heard on Live TV News Channel between 12:27:12 - 12:28:27 IST.
- Stock testing 200 day moving average at around 12,947 level.
- Witnessed strong volume of around 3.24 million shares.
- Analyst set minimum target of 1,300 level with stop loss at 1,220 on daily close basis.
- Said 200 DMA is a make-or-break level; a close above it could trigger strong upward momentum.
Also from Dr. Reddy's Laboratories
Citi upgraded Dr. Reddy's Laboratories to buy from sell, raising target price to Rs 1450
29 Sep 2026
Dr Reddy's was among the top Nifty gainers after a double upgrade from Citi
29 Sep 2026
Dr Reddy was among the top gainers on the Nifty after a double upgrade from Citi
29 Sep 2026
Source: Live TV News Channel · 29 Sep 2026
The call above is Sundar Kewat, Ashika Institutional Equities's, reported here as they made it. Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.